Target intelligence / Profile preview

Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (PIP5K1A)

Target
PIP5K1A
Molecular classification
Enzyme, Lipid kinase
01

Overview

Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (PIP5K1A) is a lipid kinase that phosphorylates phosphatidylinositol-4-phosphate (PI4P) to produce phosphatidylinositol 4,5-bisphosphate (PIP2), a key signaling lipid involved in a wide range of cellular processes, including signal transduction, cytoskeletal regulation, membrane trafficking, and cell proliferation. PIP5K1A activity is necessary for proper focal adhesion assembly, actin cytoskeleton organization, and is implicated in multiple signaling pathways such as Wnt. Structurally, PIP5K1A is a dimeric enzyme with a fold similar to that of protein kinases, and it requires dimerization for full activity. Dysregulation or overexpression of PIP5K1A is associated with cancers (including prostate cancer and glioma), neurological disorders, and increased cancer cell proliferation and survival

Other names
Phosphatidylinositol 4-phosphate 5-kinase type-1 alphaPIP5K1-alphaPtdIns(4)P-5-kinase 1 alphaPIP5KIalpha68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alphaphosphatidylinositol 4-phosphate 5-kinase type I alpha
02

Mechanism of action

Inhibition of kinase activity would reduce cellular PIP2 synthesis and downstream signaling Modulation disrupts actin cytoskeleton and cell migration

03

Biological functions

Phosphatidylinositol-4-phosphate (PI4P) phosphorylation (conversion to PIP2)Signal transduction (including Wnt signaling)Regulation of actin cytoskeleton/focal adhesion assemblyActivation of GTPase activity
04

Disease associations

Cancer (promotes cell proliferation and invasion, e.g. prostate cancer)Neurological disease (intellectual developmental disorder, autosomal dominant 60, with seizures)Glioma
05

Safety considerations

PIP5K1A is involved in essential cell processes; inhibition may disrupt cell survival, cytoskeletal dynamics, and signalingPotential for neurotoxicity and impaired cell proliferation

Beyond the preview

Go deeper on Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (PIP5K1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (PIP5K1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call